- Home
- MIST vs LFCR Comparison
MIST vs LFCR Comparison
Compare MIST & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MIST | LFCR |
|---|---|---|
| Founded | 2003 | 1986 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 176.3M | 143.9M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MIST | LFCR |
|---|---|---|
| Price | $1.91 | $4.96 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $8.00 | $5.50 |
| AVG Volume (30 Days) | ★ 2.9M | 368.3K |
| Earning Date | 05-13-2026 | 08-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | $2,915.14 | N/A |
| Revenue Next Year | N/A | $5.04 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $1.00 | $3.63 |
| 52 Week High | $3.06 | $8.98 |
Technical Indicators
Market Signals| Indicator | MIST | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 54.55 | 47.89 |
| Support Level | $1.89 | $3.63 |
| Resistance Level | $2.30 | $8.60 |
| Average True Range (ATR) | 0.18 | 0.31 |
| MACD | 0.01 | 0.12 |
| Stochastic Oscillator | 46.97 | 62.26 |
Price Performance
Historical ComparisonAbout MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.